Rate per 100,000 Population of Reported Cases by Age Group - 2012

  <1 1-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60+ Total
AIDS* 0.0 0.0 0.0 0.0 1.1 4.1 9.2 8.6 8.0 2.4 4.6
AMEBIASIS 0.0 0.8 0.4 0.5 1.0 1.3 2.1 1.8 1.0 0.9 1.2
ANAPLASMOSIS 0.0 0.2 0.9 1.6 1.5 1.2 2.7 2.7 3.8 5.3 2.8
BABESIOSIS 0.8 0.0 0.3 0.7 0.4 0.3 1.2 1.8 2.5 5.2 2.0
BOTULISM 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.04
CAMPYLOBACTERIOSIS 35.3 33.1 15.9 8.5 15.8 20.8 16.2 12.2 18.6 20.2 17.9
CHLAMYDIA NA NA NA 63.2 1484.4 1432.8 275.2 60.8 18.8 2.5 340.7
CRYPTOSPORIDIOSIS 4.1 8.5 4.4 3.0 2.8 2.8 2.1 0.9 0.6 0.6 2.0
CYCLOSPORA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.04 0.05
DENGUE FEVER 0.8 0.2 0.0 0.0 0.0 0.1 0.2 0.2 0.3 0.1 0.1
DIPHTHERIA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.01
E. COLI 0157 0.8 2.6 1.5 1.1 2.1 1.2 0.8 0.4 0.5 0.9 1.0
EHEC** 5.7 4.5 0.7 1.5 1.5 1.8 0.6 0.6 0.5 0.9 1.2
EHRLICHIOSIS 0.0 0.0 0.1 0.4 0.1 0.1 0.2 0.3 1.0 0.8 0.4
EHRLICHIOSIS/ANAPLASMOSIS UNDETERMINED 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.1
ENCEPHALITIS (NON-WESTNILE) 0.0 0.6 0.3 0.0 0.1 0.1 0.2 0.1 0.6 0.6 0.3
GIARDIASIS 5.7 10.7 12.4 7.2 4.8 9.0 8.8 8.3 9.0 6.7 8.7
GONORRHEA NA NA NA 14.6 236.5 269.3 92.1 32.7 11.4 2.0 70.3
HAEMOPHILUS INFLUENZAE 8.2 1.2 0.6 0.3 0.2 0.5 1.2 0.3 1.7 5.2 1.8
HANTAVIRUS 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.04 0.01
HEMOLYTIC UREMIC SYNDROME 2.5 0.8 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1
HEPATITIS A 0.0 0.4 0.3 1.0 1.0 0.9 0.6 0.3 0.5 0.4 0.6
HEPATITIS B - ACUTE 0.0 0.0 0.0 0.0 0.1 0.3 0.6 1.1 0.8 0.3 0.4
HEPATITIS B - CHRONIC*** 1.6 1.2 0.4 1.5 5.5 17.9 28.5 18.7 15.9 11.9 13.7
HEPATITIS C - ACUTE 0.0 0.0 0.0 0.0 0.4 2.7 1.6 0.5 0.5 0.1 0.7
HEPATITIS C, PAST/PRESENT*** 4.1 0.2 0.4 0.5 11.1 62.0 60.2 60.6 117.5 52.7 53.2
HIV**** 1.6 0.0 0.0 0.1 2.8 17.3 16.3 12.5 8.3 2.1 7.9
LABORATORY CONFIRMED INFLUENZA 597.7 382.3 339.3 158.2 123.5 122.0 130.8 90.2 81.4 167.3 160.3
LEGIONELLOSIS 0.0 0.0 0.0 0.1 0.1 0.1 0.7 1.8 4.4 8.9 2.9
LISTERIOSIS 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.4 1.3 0.4
LYMPHOGRANULOMA VENEREUM NA NA NA 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.04
MALARIA 0.0 0.2 0.6 0.3 0.6 0.4 0.5 0.5 0.4 0.1 0.4
MEASLES 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.01
MENINGITIS ASEPTIC 52.5 3.5 3.0 4.0 4.3 4.4 5.3 4.0 2.6 2.4 4.1
MENINGOCOCCAL 4.1 0.2 0.0 0.0 0.5 0.1 0.2 0.1 0.1 0.1 0.2
MENINGITIS OTHER BACT. AND UNKNOWN 0.0 0.0 0.3 0.0 0.2 0.6 0.2 0.5 0.6 0.8 0.5
MUMPS 0.0 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1
PERTUSSIS 181.2 56.6 82.5 129.5 45.8 3.9 4.4 6.0 3.1 2.7 24.2
Q FEVER 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.03
RMSF 0.0 0.2 0.3 0.4 0.1 0.2 0.2 0.4 0.2 0.2 0.2
RUBELLA 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.01
SALMONELLOSIS 57.4 26.4 13.7 8.9 11.7 13.4 9.8 11.1 9.9 11.5 12.4
SHIGELLOSIS 9.0 46.1 27.3 5.6 3.2 6.0 7.5 2.4 1.9 1.6 7.4
STREP GROUP A INVASIVE 2.5 1.0 1.2 0.5 0.6 1.2 1.7 2.4 2.7 6.8 2.8
STREP GROUP B INVASIVE 50.8 0.6 0.0 0.4 0.7 1.2 2.8 4.4 11.3 26.6 9.0
STREP PNEUMONIA INVASIVE***** 13.1 9.5 4.0 1.4 0.7 1.7 4.0 4.4 9.7 26.8 9.3
SYPHILIS EARLY NA NA NA 0.0 1.3 9.5 6.2 5.1 2.8 0.8 3.3
SYPHILIS LATE NA NA NA 0.0 0.9 3.3 6.3 9.1 7.0 6.5 5.0
TOXIC SHOCK SYNDROME 0.0 0.0 0.4 0.1 0.2 0.1 0.2 0.1 0.2 0.2 0.2
TUBERCULOSIS 0.8 0.6 0.4 0.7 1.1 2.6 2.5 1.6 1.4 3.2 1.9
TYPHOID FEVER 0.8 0.6 0.0 0.3 0.4 0.2 0.2 0.1 0.2 0.1 0.2
WEST NILE FEVER 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.3 0.6 0.2
WEST NILE VIRUS 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.6 0.8 0.3
YERSINIOSIS 2.5 0.8 0.1 0.3 0.7 0.2 0.2 0.2 0.5 0.9 0.5

Footnotes

  • * Based on year reported (excludes inmates). Includes all newly-reported AIDS cases regardless of HIV diagnosis date.
    Provisional, data as of August 8, 2013. County of residence is unknown for 6 cases.
  • **E.coli non-O157 and non-sero-grouped shigatoxin producing infection
  • *** Rate per cases as of September 11, 2013. Excludes inmates.
  • **** Based on year reported (excludes inmates). Includes all newly-reported HIV cases, regardless of concurrent or subsequent AIDS diagnosis.
    Provisional, data as of August 8, 2013.
  • *****Resistant, Sensitive, Intermediate, & Unknown